Table 1 Correlation between DIAPH2-AS1 expression and clinicopathologic parameters of 84 GC patients.
Characteristic | Number of cases (n = 84) | Number of cases | P value | |
|---|---|---|---|---|
DIAPH2-AS1low (n = 42) | DIAPH2-AS1high (n = 42) | |||
Age (years) | ||||
<60 | 20 | 10 | 10 | >0.9999 |
≥60 | 64 | 32 | 32 |  |
Gender | ||||
Male | 63 | 33 | 30 | 0.615 |
Female | 21 | 9 | 12 | Â |
Tumor size (cm) | ||||
<3 | 21 | 10 | 11 | >0.9999 |
≥3 | 63 | 32 | 31 |  |
Tumor site | ||||
Proximal | 36 | 17 | 19 | 0.826 |
Nonproximal | 48 | 25 | 23 | Â |
T stage | ||||
Tis-T2 | 21 | 15 | 6 | 0.042* |
T3-T4 | 63 | 27 | 36 | Â |
Lymph node status | ||||
Negative (N0) | 37 | 22 | 15 | 0.187 |
Positive (N1–N3) | 47 | 20 | 27 |  |
Neural invasion | ||||
Negative | 38 | 26 | 12 | 0.004** |
Positive | 46 | 16 | 30 | Â |
Tumor differentiation | ||||
Well-moderate | 31 | 20 | 11 | 0.070 |
Poor-signet | 53 | 22 | 31 | Â |
Tumor stage | ||||
I–II | 33 | 23 | 10 | 0.007** |
III | 51 | 19 | 32 | Â |